WeLeader Biomedical Co., Ltd. (TPEX:7713)
70.50
-0.30 (-0.42%)
Nov 20, 2026, 1:24 PM CST
WeLeader Biomedical Revenue
WeLeader Biomedical had revenue of 352.70M TWD in the quarter ending September 30, 2026, with 19.20% growth. This brings the company's total for the last twelve months to 1.27B, up 19.20% year-over-year. In the year 2025, WeLeader Biomedical had annual revenue of 1.11B with 11.92% growth. That makes WeLeader Biomedical the 29,867th largest company in the world by revenue and 1,459th in Taiwan.
Revenue (ttm)
1.27B
Revenue Growth
+19.20%
P/S Ratio
2.53
Revenue / Employee
n/a
Employees
201
Market Cap
3.21B
Revenue by Segment
- The Company 921.45M 82.7%
- Health Leader Biomedical Co., Ltd. 192.86M 17.3%
Fiscal year ended Dec 31, 2025 See the full WeLeader Biomedical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.11B | 118.18M | 11.92% |
| Dec 31, 2024 | 991.13M | 50.43M | 5.36% |
| Dec 31, 2023 | 940.70M | -95.02M | -9.17% |
| Dec 31, 2022 | 1.04B | 194.58M | 23.13% |
| Dec 31, 2021 | 841.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| United Orthopedic | 6.10B |
| Hi-Clearance | 4.51B |
| InnoCare Optoelectronics | 3.07B |
| Wellell | 2.56B |
| Apex Biotechnology | 1.86B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| A Plus Biotechnology | 919.38M |